EGFR and colorectal carcinoma: Moreover, we selected only left colon tumors as samples to rule out the bias from different locations of CRC, because the new NCCN guidelines of colon cancer have already mentioned that anti‐EGFR therapy has relatively lower benefits on the right‐sided colon compared with the left‐sided colon.